New hope for pancreatic cancer? drug combo trial shows promise
Disease control
Completed
This study tested whether adding two experimental drugs (TTX-030 and budigalimab) to standard chemotherapy could help people with metastatic pancreatic cancer live longer without their disease getting worse. 194 adults who had not yet received treatment for their advanced cancer …
Phase: PHASE2 • Sponsor: Trishula Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC